Published in J Gastroenterol on October 11, 2015
Genetic basis of hepatitis virus-associated hepatocellular carcinoma: linkage between infection, inflammation, and tumorigenesis. J Gastroenterol (2016) 0.78
Is Hepatocellular Cancer the Same Disease in Alcoholic and Nonalcoholic Fatty Liver Diseases? Gastroenterology (2016) 0.76
Nonalcoholic fatty liver disease in Asia: emerging perspectives. J Gastroenterol (2016) 0.76
Evaluation of the Efficacy of Sorafenib on Overall Survival in Patients with Hepatocellular Carcinoma using FT Rate: A Devised Index. Adv Ther (2017) 0.75
The prognosis of hepatitis B inactive carriers in Japan: a multicenter prospective study. J Gastroenterol (2016) 0.75
Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology (2005) 29.57
Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol (1999) 14.07
Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology (2003) 8.75
The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. Hepatology (2010) 4.83
Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma. Gastroenterology (2009) 4.50
Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings. Hepatology (2011) 3.46
Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer (2000) 3.23
Base excision repair of oxidative DNA damage and association with cancer and aging. Carcinogenesis (2008) 2.42
Report of the 17th Nationwide Follow-up Survey of Primary Liver Cancer in Japan. Hepatol Res (2007) 2.29
Hepatocellular carcinoma occurring in nonfibrotic liver: epidemiologic and histopathologic analysis of 80 French cases. Hepatology (2000) 2.21
Staging of hepatocellular carcinoma: assessment of the Japanese TNM and AJCC/UICC TNM systems in a cohort of 13,772 patients in Japan. Ann Surg (2007) 1.82
Characteristics of patients with nonalcoholic steatohepatitis who develop hepatocellular carcinoma. Clin Gastroenterol Hepatol (2011) 1.56
Factors associated with early recurrence after resection for hepatocellular carcinoma and outcomes. J Am Coll Surg (2005) 1.50
Clinical features and outcomes of cirrhosis due to non-alcoholic steatohepatitis compared with cirrhosis caused by chronic hepatitis C. J Gastroenterol Hepatol (2008) 1.49
Recurrence patterns after hepatectomy of hepatocellular carcinoma: implication of Milan criteria utilization. Ann Surg Oncol (2009) 1.30
Nonalcoholic steatohepatitis-associated hepatocellular carcinoma: our case series and literature review. World J Gastroenterol (2010) 1.28
Etiology of liver cirrhosis in Japan: a nationwide survey. J Gastroenterol (2009) 1.16
Hepatocellular carcinoma in non-alcoholic steatohepatitis: Growing evidence of an epidemic? Hepatol Res (2011) 1.15
Management of hepatocellular carcinoma: Report of Consensus Meeting in the 45th Annual Meeting of the Japan Society of Hepatology (2009). Hepatol Res (2010) 1.11
Prospective study of hepatocellular carcinoma in nonalcoholic steatohepatitis in comparison with hepatocellular carcinoma caused by chronic hepatitis C. J Gastroenterol (2010) 1.08
Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease, alcoholic liver disease, and chronic liver disease of unknown etiology: report of the nationwide survey. J Gastroenterol (2011) 1.06
Primary liver cancers with nonalcoholic steatohepatitis. Eur J Gastroenterol Hepatol (2007) 1.05
Multicausality in fatty liver disease: is there a rationale to distinguish between alcoholic and non-alcoholic origin? World J Gastroenterol (2012) 1.05
Alcohol consumption is associated with progression of hepatic fibrosis in non-alcoholic fatty liver disease. Scand J Gastroenterol (2009) 1.01
Role of endoplasmic reticulum stress in the pathogenesis of nonalcoholic fatty liver disease. World J Gastroenterol (2014) 1.00
ASH and NASH. Dig Dis (2011) 1.00
What studies on human longevity tell us about the risk for cancer in the oldest old: data and hypotheses on the genetics and immunology of centenarians. Exp Gerontol (2002) 0.97
Clinical characteristics, treatment, and prognosis of non-B, non-C hepatocellular carcinoma: a large retrospective multicenter cohort study. J Gastroenterol (2014) 0.93
Nonalcoholic steatohepatitis: risk factors for liver fibrosis. Hepatol Res (2002) 0.90
Imaging of nonalcoholic steatohepatitis: advantages and pitfalls of ultrasonography and computed tomography. Intern Med (2009) 0.89
Sectionectomy is suitable for patients with T2 hepatocellular carcinoma according to the modified international union against cancer TNM Classification. Dig Surg (2007) 0.82
A variant of des-gamma-carboxy prothrombin was increased in alcoholic liver disease without hepatocellular carcinoma. Alcohol Clin Exp Res (2001) 0.80
Hepatocellular carcinoma based on cryptogenic liver disease: The most common non-viral hepatocellular carcinoma in patients aged over 80 years. Hepatol Res (2014) 0.79
[The history of the diagnostic criteria for alcoholic liver disease and current status of alcoholic liver disease in Japan]. Nihon Shokakibyo Gakkai Zasshi (2012) 0.78
Alcohol consumption and recurrence of non-B or non-C hepatocellular carcinoma after hepatectomy: a propensity score analysis. J Gastroenterol (2013) 0.78
Induction of cross-linking and silencing of Sp1 by transglutaminase during liver injury in ASH and NASH via different ER stress pathways. Dig Dis (2011) 0.78
Increasing prevalence of diabetes mellitus in association with fatty liver in a Japanese population. J Gastroenterol (2013) 0.78
Comparison of ADA and WHO screening methods for diabetes mellitus in obese patients. American Diabetes Association. Diabet Med (1999) 0.75
Increase of Serum Des-gamma-Carboxy Prothrombin in Alcoholic Liver Disease Without Hepatocellular Carcinoma. Alcohol Clin Exp Res (1999) 0.75
Hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. J Gastroenterol (2009) 1.64
Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography. Gastroenterology (2015) 1.63
Randomized trial of interferon- and ribavirin-free ombitasvir/paritaprevir/ritonavir in treatment-experienced hepatitis C virus-infected patients. Hepatology (2015) 1.24
Evaluation of Ki-67 index in EUS-FNA specimens for the assessment of malignancy risk in pancreatic neuroendocrine tumors. Endoscopy (2013) 1.19
Drug-Drug Interactions in Patients Co-infected With HCV and HIV. JAMA (2015) 1.08
Diagnosis of Helicobacter pylori-induced gastritis by serum pepsinogen levels. J Gastroenterol Hepatol (2015) 0.86
Lower levels of insulin-like growth factor-1 standard deviation score are associated with histological severity of non-alcoholic fatty liver disease. Hepatol Res (2014) 0.85
A novel noninvasive diagnostic method for nonalcoholic steatohepatitis using two glycobiomarkers. Hepatology (2015) 0.83
The impact of PNPLA3 and JAZF1 on hepatocellular carcinoma in non-viral hepatitis patients with type 2 diabetes mellitus. J Gastroenterol (2015) 0.81
Overexpression of NF90-NF45 Represses Myogenic MicroRNA Biogenesis, Resulting in Development of Skeletal Muscle Atrophy and Centronuclear Muscle Fibers. Mol Cell Biol (2015) 0.81
A successful case of deceased donor liver transplantation for a patient with intrahepatic arterioportal fistula. Hepatol Res (2016) 0.80
Acute hepatitis C in HIV-1 infected Japanese Cohort: single center retrospective cohort study. PLoS One (2014) 0.80
Multikinase inhibitor regorafenib inhibits the growth and metastasis of colon cancer with abundant stroma. Cancer Sci (2016) 0.79
Biphasic effect of alcohol intake on the development of fatty liver disease. J Gastroenterol (2015) 0.79
Predictors of malignancies and overall mortality in Japanese patients with biopsy-proven non-alcoholic fatty liver disease. Hepatol Res (2014) 0.78
Analysis of Hepatitis C Virus Genotype 1b Resistance Variants in Japanese Patients Treated with Paritaprevir-Ritonavir and Ombitasvir. Antimicrob Agents Chemother (2015) 0.78
Copper Accumulates in Hemosiderins in Livers of Patients with Iron Overload Syndromes. J Clin Transl Hepatol (2015) 0.77
Transarterial therapy of hepatocellular carcinoma fed by the right renal capsular artery. J Vasc Interv Radiol (2014) 0.77
ADH1B and ALDH2 are associated with metachronous SCC after endoscopic submucosal dissection of esophageal squamous cell carcinoma. Cancer Med (2016) 0.77
Angiotensinogen gene haplotype is associated with the prevalence of Japanese non-alcoholic steatohepatitis. Hepatol Res (2011) 0.77
Serum alanine aminotransferase predicts the histological course of non-alcoholic steatohepatitis in Japanese patients. Hepatol Res (2014) 0.77
Uric acid levels decrease with fibrosis progression in patients with nonalcoholic fatty liver disease. Clin Biochem (2014) 0.77
Insulin resistance increases the risk of incident type 2 diabetes mellitus in patients with nonalcoholic fatty liver disease. Hepatol Res (2017) 0.77
Serum YKL-40 as a marker of liver fibrosis in patients with non-alcoholic fatty liver disease. Sci Rep (2016) 0.76
Reduced phosphorylation of ribosomal protein S6 is associated with sensitivity to MEK inhibition in gastric cancer cells. Cancer Sci (2016) 0.76
The 'donations for decreased ALT (D4D)' prosocial behavior incentive scheme for NAFLD patients. J Public Health (Oxf) (2013) 0.76
Hepatitis B virus evades innate immunity of hepatocytes but activates macrophages during infection. Hepatology (2017) 0.75
Autoantibody status and histological variables influence biochemical response to treatment and long-term outcomes in Japanese patients with primary biliary cirrhosis. Hepatol Res (2014) 0.75
New genetic biomarkers predicting azathioprine blood concentrations in combination therapy with 5-aminosalicylic acid. PLoS One (2014) 0.75
Lubiprostone improves intestinal permeability in humans, a novel therapy for the leaky gut: A prospective randomized pilot study in healthy volunteers. PLoS One (2017) 0.75
Are donors or recipients a more important predictive factor for the development of non-alcoholic fatty liver disease after liver transplantation? Hepatol Res (2017) 0.75
Effect of 12-week dulaglutide therapy in Japanese patients with biopsy-proven non-alcoholic fatty liver disease and type 2 diabetes mellitus. Hepatol Res (2016) 0.75
Spur cells and acanthocytes in liver diseases. Hepatol Res (2007) 0.75
Are genetic variations the most important risk factors for development of hepatocellular carcinoma? J Gastroenterol (2015) 0.75
Effect of sodium glucose cotransporter 2 inhibitor on liver function tests in Japanese patients with non-alcoholic fatty liver disease and type 2 diabetes mellitus. Hepatol Res (2016) 0.75
Morbidly obese patient with non-alcoholic steatohepatitis-related cirrhosis who died from sepsis caused by dental infection of Porphyromonas gingivalis: A case report. Hepatol Res (2015) 0.75
Integrated Resistance Analysis of CERTAIN-1 and CERTAIN-2 Studies in HCV Infected Patients Receiving Glecaprevir and Pibrentasvir in Japan. Antimicrob Agents Chemother (2017) 0.75
Resistance Characterization of Hepatitis C Virus Genotype 2 from Japanese Patients Treated with Ombitasvir and Paritaprevir/Ritonavir. J Med Virol (2017) 0.75
Combination of PNPLA3 and TLL1 polymorphism can predict advanced fibrosis in Japanese patients with nonalcoholic fatty liver disease. J Gastroenterol (2017) 0.75
Evolution of Survival Impact of Molecular Target Agents in Patients with Advanced Hepatocellular Carcinoma. Liver Cancer (2021) 0.75
Efficacy of glutathione for the treatment of nonalcoholic fatty liver disease: an open-label, single-arm, multicenter, pilot study. BMC Gastroenterol (2017) 0.75
Prevalence of pruritus in patients with chronic liver disease: a multicenter study. Hepatol Res (2017) 0.75
Pemafibrate suppresses NLRP3 inflammasome activation in the liver and heart in a novel mouse model of steatohepatitis-related cardiomyopathy. Sci Rep (2022) 0.75
Characteristics of gastric cancer in negative test of serum anti-Helicobacter pylori antibody and pepsinogen test: a multicenter study. Gastric Cancer (2016) 0.75
Novel antidiabetic medications for nonalcoholic fatty liver disease with type 2 diabetes. Hepatol Res (2016) 0.75
Transarterial chemoembolization with miriplatin vs. epirubicin for unresectable hepatocellular carcinoma: a phase III randomized trial. J Gastroenterol (2017) 0.75
Vaniprevir plus peginterferon alfa-2b and ribavirin in treatment-experienced Japanese patients with hepatitis C virus genotype 1 (GT1b) infection: Phase 3 studies. J Gastroenterol Hepatol (2016) 0.75
Effects of canagliflozin, an SGLT2 inhibitor, on hepatic function in Japanese patients with type 2 diabetes mellitus: pooled and subgroup analyses of clinical trials. J Gastroenterol (2017) 0.75
Simultaneous occurrence of gastric lipoma and early gastric cancer. Endoscopy (2014) 0.75
Liver stiffness measurement to platelet ratio index predicts the stage of liver fibrosis in non-alcoholic fatty liver disease. Hepatol Res (2016) 0.75
Real-time monitoring of trans-epithelial electrical resistance in cultured intestinal epithelial cells: the barrier protection of water-soluble dietary fiber. J Dig Dis (2017) 0.75